Mesoblast | MSB - Current Liabilities


Mesoblast reported $128.07M in Current Liabilities for its fiscal semester ending in December of 2025.





Current Liabilities Change Date
Avita Medical AUD 62.68M 77K Dec/2025
Clinuvel Pharmaceuticals AUD 17.85M 9.36M Dec/2025
Cochlear AUD 558.9M 43.4M Dec/2025
CSL USD 4.61B 207M Dec/2025
Pacific Edge NZD 7.22M 2.54M Dec/2025
Paradigm Biopharmaceuticals AUD 16.6M 13.37M Dec/2025
PYC Therapeutics AUD 11.01M 1.31M Dec/2025
Ramsay Health Care AUD 3.95B 514.2M Dec/2025
Sonic Healthcare AUD 2.23B 92.84M Dec/2024
Starpharma Holdings AUD 4.61M 614K Dec/2025
Telix Pharmaceuticals AUD 231.62M 66.96M Dec/2025